SPRO

NASDAQStock

Spero Therapeutics, Inc.

$2.58-0.01 (-0.58%)

52-Week Range

$0.56

$3.04

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

1.53

Volume

171.8K

Avg Volume

318.9K

Performance

+8.82%

+13.10%

+37.77%

YTD

+10.21%

+231.03%

+76.19%

-84.59%

Price Chart

ETF Exposure

SPRO is held by 10 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
QQQS	Invesco NASDAQ Future Gen 200 ETF	0.52%	27,529	$71K	$13.4M	0.20%
VXF	Vanguard Extended Market ETF	0.00%	516,108	$1.1M	$84.10B	0.05%
DFAC	Dimensional - US Core Equity 2 ETF	0.00%	4,874	$13K	$40.55B	0.17%
DFAS	Dimensional - US Small Cap ETF	0.00%	15,934	$41K	$12.65B	0.26%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	60	$180	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	2,172	$6K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	10	$31	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	1,236,776	$2.7M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	6,505	$19K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	560	$2K	$1.29B	0.17%

About SPRO ETF Exposure

Spero Therapeutics, Inc. (SPRO) is held by 10 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $2.58. Investors can gain exposure to SPRO through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold SPRO, sorted by portfolio weight.